8:40–10:05 A.M. SESSION I: CO-DEVELOPMENT
   
  Moderator:
   
 

Victoria Pratt

 

Chief Director, Molecular Genetics

 

Quest Diagnostics Nichols Institute

8:40–9:00 A.M. Effectiveness of Co-Development
   
 

Felix Frueh

 

Entrepreneur-in-Residence

 

Third Rock Ventures

9:00–9:20 A.M. FDA Review of Co-Development to Date
   
 

Elizabeth Mansfield

 

Director, Personalized Medicine Staff

 

Office of In Vitro Diagnostics and Radiological Health

 

Center for Devices and Radiological Health

 

U.S. Food and Drug Administration

9:20–10:05 A.M. Discussion with Speakers and Attendees
   
10:05–10:20 A.M. BREAK
   
10:20 A.M.–12:05 P.M. SESSION II: CHALLENGES AND OPPORTUNITIES
   
10:20–10:40 A.M. Stakeholder Input on the Current Co-Development Paradigm
   
 

Robert McCormack

 

Head, Technology Innovation and Strategy

 

Veridex LLC



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement